A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …
Category: Federal
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...] …
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...] …
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...] …
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...] …
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...] …
President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...] …